- Corporate Officers - G
- Gerberding Julie L.
Insider Trading History of Gerberding Julie L.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gerberding Julie L. since 2015.
This trader's CIK number is 1628884.
At the time of last reporting, Gerberding Julie L. was the EVP, Chief Patient Officer of Merck & Co., Inc.. (stock ticker symbol MRK).
Also see all insider trading activities at Merck & Co., Inc..
Note that in the past
Gerberding Julie L. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cerner Corp (CERN) by Gerberding Julie L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CERN | 0 | $0 | 7,928 | $569,388 | 0 | $0 |
Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Gerberding Julie L.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | MRK | 0 | $0 | 96,270 | $8,462,710 | 96,270 | $0 |
| 2020 | MRK | 0 | $0 | 138,358 | $12,021,876 | 100,659 | $0 |
| 2018 | MRK | 0 | $0 | 46,190 | $3,316,307 | 36,218 | $1,980,400 |
| 2017 | MRK | 0 | $0 | 0 | $0 | 3,092 | $0 |
| 2016 | MRK | 0 | $0 | 85,523 | $5,133,347 | 89,525 | $3,444,609 |
| 2015 | MRK | 0 | $0 | 38,368 | $2,339,949 | 50,026 | $1,618,435 |
Insider trading activities at 2 companies by Gerberding Julie L.:
1. Cerner Corp (CERN)
2. Merck & Co., Inc. (MRK)
Table 1. Insider trading of Cerner Corp (CERN) by Gerberding Julie L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-08-22 | CERN | Sale | 7,928 | 71.82 | 569,388 |
Table 2. Insider trading of Merck & Co., Inc. (MRK) by Gerberding Julie L.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-01 | MRK | Sale | 96,270 | 87.91 | 8,462,710 |
| 2021-11-01 | MRK | Option Ex | 96,270 | .00 | 0 |
| 2020-07-17 | MRK | Option Ex | 18,111 | .00 | 0 |
| 2020-07-17 | MRK | Sale | 36,285 | 80.00 | 2,902,981 |
| 2020-01-13 | MRK | Option Ex | 82,548 | .00 | 0 |
| 2020-01-13 | MRK | Sale | 102,073 | 89.34 | 9,118,895 |
| 2018-11-07 | MRK | Option Ex | 36,218 | 54.68 | 1,980,400 |
| 2018-11-07 | MRK | Sale | 36,218 | 75.14 | 2,721,348 |
| 2018-05-15 | MRK | Sale | 9,972 | 59.66 | 594,959 |
| 2017-05-02 | MRK | Option Ex | 3,092 | .00 | 0 |
| 2016-11-07 | MRK | Option Ex | 85,523 | 40.28 | 3,444,609 |
| 2016-11-07 | MRK | Sale | 85,523 | 60.02 | 5,133,347 |
| 2016-05-06 | MRK | Option Ex | 4,002 | .00 | 0 |
| 2015-05-08 | MRK | Option Ex | 46,208 | 35.02 | 1,618,435 |
| 2015-05-08 | MRK | Sale | 38,368 | 60.99 | 2,339,949 |
| 2015-05-02 | MRK | Option Ex | 3,818 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gerberding Julie L.
(EVP, Chief Patient Officer of Merck & Co., Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.